TLR3 and squamous cell carcinoma: Sensitivity to the artificial TLR3 ligand poly(I:C) upon treatment with IAP antagonist or TWEAK was studied in HaCaT keratinocytes, A5RT3, and MET-1 squamous cell carcinoma (SCC) cells.